PHARMACEUTICAL COMPOSITIONS FOR PIPERIDINOALKANOL COMPOUNDS

摘要

The invention provides a pharmaceutical composition in solid unit dosage form prepared by wet granulation process comprising, (a) a therapeutically effective amount of a piperidinoalkanol compound, or a pharmaceutically acceptable salt, or individual optical isomers thereof, (b) at least one functional excipient (preferably a diluent or mixture of diluents), mixed with a solution of a binding agent; the wet granulation is screened, the wet granulation is dried, the dry granulation is screened and the dry granulation is blended with at least one disintegrant.